India Semaglutide ‘Bloodbath,’ Rx Memory And Regulatory Warning On Promos

 
• By Anju Ghangurde
  
obesity
Indian regulator cautions pharma on GLP-1 RA ads ahead of semaglutide LOE (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Regional Comparisons

More from Pink Sheet